TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
AURA

Aura Biosciences Inc

Healthcare · Biotechnology

6.50$ +1.4% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow AURA
Line item 2019 2020 2021 2022 2023 2024 2025
+63.3% +0.0% +41.6% +10.0% -5.6% -7.7%
+45.2% +213.5% +177.9% +36.8% +33.6% +22.1%
+30.7% +216.6% +162.3%
-249.3% -159.5%
-65.3% +175.6% -48.5% -35.2% +76.7% -64.3%
-65.3% +175.6% +3,093.8% +67.9% -48.3%
-100.0% -47.6%
-8.1%
-74.7% +1,556.6% -42.5% +1.7% -98.4% +4,737.3%
-189.4% -120.4%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?